LA
RPRX icon

LBP AM’s Royalty Pharma RPRX Stock Holding History

LBP AM’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Sell
22,589
-3,637
-14% -$189K 0.01% 356
2026
Q1 		$1.26M Buy
26,226
+9,080
+53% +$398K 0.02% 321
2025
Q4 		$663K Hold
17,146
– – 0.01% 380
2025
Q3 		$605K Sell
17,146
-847
-5% -$30.7K 0.01% 358
2025
Q2 		$648K Sell
17,993
-2,026
-10% -$67.1K 0.01% 344
2025
Q1 		$623K Hold
20,019
– – 0.01% 335
2024
Q4 		$511K Hold
20,019
– – 0.01% 342
2024
Q3 		$566K Hold
20,019
– – 0.01% 328
2024
Q2 		$528K Buy
+20,019
New +$555K 0.02% 302

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LBP AM's RPRX Position: Q2 2026 in Review

LBP AM reduced its Royalty Pharma (RPRX) stake by 14% in Q2 2026, selling an estimated $189K and leaving 22,589 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #356.

LBP AM first reported a position in RPRX in Q2 2024 and has held it in 9 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • LBP AM held 22,589 shares of Royalty Pharma worth $1.27M as of Q2 2026.
  • LBP AM sold 3,637 Royalty Pharma shares in Q2 2026, an estimated $189K.
  • Royalty Pharma made up 0.01% of LBP AM's portfolio in Q2 2026, its #356 holding.
  • LBP AM first reported a position in Royalty Pharma in Q2 2024 and has held it in 9 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on LBP AM's 13F filing for Q2 2026, filed 24 Jul 2026.